Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/18960
Title: | PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN |
Authors: | Gupta, A Anjomani-Virmouni, S Koundouros, N Poulogiannis, G |
Keywords: | Cancer;Nitrosative stress;PARK2;PTEN;S-nitrosylation |
Issue Date: | 19-May-2017 |
Publisher: | Taylor & Francis |
Citation: | Molecular and Cellular Oncology, 2017, 4 (6), pp. 1 - 2 |
Abstract: | Cancer and Parkinson disease (PD) derive from distinct alterations in cellular processes, yet there are pathogenic mutations that are unequivocally linked to both diseases. Here we expand on our recent findings that loss of parkin RBR E3 ubiquitin protein ligase (PRKN, best known as PARK2)—which is genetically linked to PD—promotes cancer progression via redox-mediated inactivation of phosphatase and tensin homolog (PTEN) by S-nitrosylation. |
URI: | http://bura.brunel.ac.uk/handle/2438/18960 |
DOI: | http://dx.doi.org/10.1080/23723556.2017.1329692 |
ISSN: | 2372-3556 http://dx.doi.org/10.1080/23723556.2017.1329692 |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 1.92 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.